Recontacting in clinical genetics and genomic medicine¿ We need to talk about it

European Journal of Human Genetics

Volumn 25, Issue 5, 2017, Pages 520-521

  Carrieri, Daniele ^a   Dheensa, Sandi ^b   Doheny, Shane ^c   Clarke, Angus J ^c   Turnpenny, Peter D ^d   Lucassen, Anneke M ^b   Kelly, Susan E ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL GENETICS; DUTY TO RECONTACT; HUMAN; LETTER; PATIENT PREFERENCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; UNITED KINGDOM; GENOMICS; HIGH THROUGHPUT SEQUENCING;

DUTY TO RECONTACT; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS;

EID: 85011844279     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2017.8     Document Type: Letter

References (9)

1. Levenson D: Legal and ethical issues loom over topic of recontacting patients. Am J Med Genet 2015; 167: vii-viii.
2. Otten E, Plantinga M, Birnie E et al: Is there a duty to recontact in light of new genetic technologies? A systematic review of the literature. Genet Med 2014, 17: 668-678.
3. Carrieri D, Lucassen AM, Clarke AJ et al: Recontact in clinical practice: a survey of clinical genetics services in the United Kingdom. Genet Med 2016; 18: 876-881.
4. Carrieri D, Dheensa S, Doheny S et al: Recontacting in clinical practice: an investigation of the views of healthcare professionals and clinical scientists in the United Kingdom. Eur J Hum Genet 2017; 25: 275-279.
5. Fitzpatrick JL, Han C, Costa T et al: The duty to recontact: attitudes of service providers. Am J Hum Genet 1999; 64: 852-860.
6. Hirschhorn K, Fleisher LD, Godmilow L et al: Duty to re-contact. Policy statement: social ethical and legal issues committee of the American College of Medical Geneticists. Genet Med 1999; 1: 171-172.
7. Wouters RH, Bijlsma RM, Ausems MG et al: Am i my family's keeper? Disclosure dilemmas in next generation sequencing. Hum Mutat 2016; 12: 1257-1262.
8. Almqvist E, Adam S, Bloch M et al: Risk reversals in predictive testing for Huntington disease. Am J Hum Genet 1997; 61: 945-952.
9. Godard B, Kääriäinen H, Kristoffersson U et al: Provision of genetic services in Europe: current practices and issues. Eur J Hum Genet 2003; 11: S13-S48.